Clinical Trials Directory

Trials / Completed

CompletedNCT04982341

HFNC and Prone Positioning in Awake Patients With Severe COVID-19

Effectiveness of High-flow Nasal Cannula and Prone Positioning in Awake Patients With COVID-19 and Severe Acute Respiratory Failure

Status
Completed
Phase
Study type
Observational
Enrollment
120 (actual)
Sponsor
Hôpital Universitaire Fattouma Bourguiba · Academic / Other
Sex
All
Age
Healthy volunteers

Summary

The investigators evaluate the effects of High-flow nasal cannula (HFNC) in association with prone in patients with Covid-19 severe ARF.

Detailed description

The investigators evaluate the effects of High-flow nasal cannula (HFNC) in association with prone in patients with Covid-19 severe ARF. All patients with ARF related to Covid-19 and admitted to the ICU are turned in prone position whenever tolerated, while receiving oxygenation with HFNC. Outcomes of interest are the rate of success or failure (defined as the need for intubation and mechanical ventilation)

Conditions

Interventions

TypeNameDescription
PROCEDUREprone positionpatients are returned from prone to supine position while receiving oxygenation through HFNC

Timeline

Start date
2020-09-02
Primary completion
2021-03-03
Completion
2021-03-03
First posted
2021-07-29
Last updated
2021-07-29

Locations

1 site across 1 country: Tunisia

Source: ClinicalTrials.gov record NCT04982341. Inclusion in this directory is not an endorsement.